RTG 3112 funded for an initial phase of 5 years (2025-2030) by the DFG
The research in EpiSignal studies crosstalk of intracellular signaling pathways and chromatin modification networks. EpiSignal aims to make contributions to the understanding of the regulation of cell differentiation and proliferation during normal development, shed new light onto the complex networks and regulatory principles of cell and epigenome signaling systems, and provide insights into processes occurring during diseases. Moreover, EpiSignal will establish an interdisciplinary training program that offers innovative training in all relevant disciplines (cell biology, biochemistry, molecular (epi)genetics and systems biology) and optimally prepares doctoral researchers for future career paths in academia or industry.
Contact Us

General contact email
episignal@ibc.uni-stuttgart.de

Albert Jeltsch
Prof. Dr.Acting Director Institute of Biochemistry, Speaker EpiSignal RTG
Sara Weirich
Dr.Group leader Institute of Biochemistry, Program manager EpiSignal RTG